Stay updated with breaking news from Quotient Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the...
/PRNewswire/ -- Quotient Sciences, a drug development and manufacturing accelerator, has completed major investments and expansions at its Nottingham, UK and...
Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities NOTTINGHAM, England, Sept. 22, 2022 /PRNewswire/ -- Quotient Sciences
Partnership further expedites Ensysce's development pipeline NOTTINGHAM, England, Aug. 31, 2022 /PRNewswire/ -- Ensysce Biosciences, Inc., a clinical-stage biotech company applying transformative